{"id":562274,"date":"2021-09-09T12:22:01","date_gmt":"2021-09-09T12:22:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=562274"},"modified":"2021-09-09T12:22:01","modified_gmt":"2021-09-09T12:22:01","slug":"common-warts-epidemiology-forecast-report-2030-common-warts-epidemiology-analysis-2030-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/common-warts-epidemiology-forecast-report-2030-common-warts-epidemiology-analysis-2030-delveinsight_562274.html","title":{"rendered":"Common Warts Epidemiology Forecast Report 2030 | Common Warts Epidemiology Analysis 2030 | DelveInsight"},"content":{"rendered":"
\n
\"Common<\/a><\/div>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s ‘Common Warts – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Common Warts epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/div>\n

DelveInsight launched a new report on Common Warts Epidemiology Forecast, 2030.<\/a><\/strong><\/p>\n

Warts are raised bumps on the skin that are caused by human papillomavirus (HPV). “Common warts” also known as Verruca Vulgaris, are the most common type of warts and usually grow on the fingers and toes, and also can appear elsewhere. They are characterized by a rough, grainy appearance and a rounded top. <\/p>\n

DelveInsight’s ‘Common Warts Epidemiology Forecast to 2030‘<\/strong><\/a> report delivers an in-depth understanding of the disease, historical and forecasted Common Warts epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n

\"\"<\/p>\n

Some of the key highlights from the Common Warts Epidemiology Report:<\/strong><\/p>\n

    \n
  1. \n

    Common warts are usually asymptomatic but sometimes they can cause mild pain when they are located on a weight-bearing surface (e.g., bottom of the feet). They are more common in young adults and children. A common wart can range in size from a pinhead to 10 mm. The disease is more common in males than females.<\/p>\n<\/li>\n

  2. \n

    As per various epidemiological studies, among all the other wart types, about 70% of the wart occurrences are common warts (Verruca Vulgaris), with most appearing on hands and occurring primarily in children.<\/p>\n<\/li>\n<\/ol>\n

    Visit for more @ Common Warts Epidemiology Insights<\/a><\/strong><\/p>\n

    Scope of the Common Warts Epidemiology report:<\/strong><\/p>\n

      \n
    1. \n

      The Common Warts report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns<\/p>\n<\/li>\n

    2. \n

      The Common Warts Epidemiology Report and Model provide an overview of the risk factors and global trends of Common Warts in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)<\/p>\n<\/li>\n

    3. \n

      The report provides insight into the historical and forecasted patient pool of Common Warts in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan<\/p>\n<\/li>\n

    4. \n

      The report helps to recognize the growth opportunities in the 7MM concerning the patient population<\/p>\n<\/li>\n

    5. \n

      The report assesses the disease risk and burden and highlights the unmet needs of Common Warts<\/p>\n<\/li>\n

    6. \n

      The report provides the segmentation of the Common Warts epidemiology<\/p>\n<\/li>\n<\/ol>\n

      Table of Contents:<\/strong><\/p>\n

      1. Key Insights<\/p>\n

      2. Executive Summary of Common Warts<\/p>\n

      3. Common Warts Epidemiology Overview at a Glance<\/p>\n

      4. Common Warts: Disease Background and Overview<\/p>\n

      5. Epidemiology and Patient Population<\/p>\n

      6. Case Reports<\/p>\n

      7. Country Wise-Epidemiology of Common Warts <\/p>\n

      8. Appendix<\/p>\n

      9. DelveInsight Capabilities<\/p>\n

      10. Disclaimer<\/p>\n

      11. About DelveInsight<\/p>\n

      Related Reports:<\/strong><\/p>\n

      Common Warts Market<\/a><\/strong><\/p>\n

      DelveInsight’s ‘Common Warts-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), <\/p>\n

      Common Warts Pipeline<\/a><\/strong><\/p>\n

      “Common Warts Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Common Warts market. A detailed picture of the Common Warts pipeline landscape is provided, which includes the disease overview and Common Warts treatment guidelines.<\/p>\n

      Media Contact<\/span>
      Company Name:<\/strong>       DelveInsight Business Research LLP<\/a>
      Contact Person:<\/strong> Kritika Rehani
      Email:<\/strong>       Send Email<\/a>
      Phone:<\/strong> 9193216187
      Address:<\/strong>304 S. Jones Blvd #2432
      City:<\/strong> Las Vegas
      State:<\/strong> Nevada
      Country:<\/strong> United States
      Website:<\/strong>       https:\/\/www.delveinsight.com\/<\/a><\/p>\n

      <\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

      DelveInsight Business Research LLP DelveInsight’s ‘Common Warts – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Common Warts epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-562274","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/562274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=562274"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/562274\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=562274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=562274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=562274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}